Zomedica Corp. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Zomedica Corp. stock issued during period, value, issued for services for the quarter ending 2021-12-31 was $0.00.
- Zomedica Corp. stock issued during period, value, issued for services for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- Zomedica Corp. stock issued during period, value, issued for services for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- Zomedica Corp. stock issued during period, value, issued for services for the quarter ending 2021-03-31 was $199.53M, a 7881.00% increase year-over-year.
- Zomedica Corp. stock issued during period, value, issued for services for fiscal 2021 was $199.53M, a 253.16% increase from fiscal 2020.
- Zomedica Corp. stock issued during period, value, issued for services for fiscal 2020 was $56.50M, a 7032.43% increase from fiscal 2019.
- Zomedica Corp. stock issued during period, value, issued for services for fiscal 2019 was $792.10K, a 85.98% decline from fiscal 2018.
- Zomedica Corp. stock issued during period, value, issued for services for fiscal 2018 was $5.65M, a 1954.17% increase from fiscal 2017.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $199.53M 10-K · filed 2023-03-15 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $199.53M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $228.06M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $199.53M 10-Q · filed 2022-05-10 | $253.52M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $56.50M 10-K · filed 2022-03-01 |
| 2020-09-30 | $28.53M 10-Q · filed 2021-11-12 | $56.50M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $25.46M 10-Q · filed 2021-08-11 | $27.96M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $2.50M 10-Q · filed 2021-05-12 | $2.50M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $792.10K 10-K · filed 2021-02-26 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $5.21M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $5.21M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $792.10K 10-Q · filed 2020-05-11 | |
| 2018-12-31 | $4.41M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $5.65M 10-K · filed 2020-02-26 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | |
| 2017-12-31 | $230.13K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-03-14 | $275.13K 10-K/A · filed 2019-03-14 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | |
| 2017-03-31 | $45.00K 10-Q · filed 2018-05-15 | |
| 2016-12-31 | $15.74K 10-K · filed 2018-02-28 |